Matthew Shair's Planned Sale of Nuvalent Inc Class A Common Shares

Matthew Shair, a director of Nuvalent Inc, has filed a notice of intent to sell 18,150 Class A Common shares of Nuvalent Inc. The shares, which were acquired on July 13, 2021, are held in the Matthew Shair 2021 Irrevocable Trust. The sale is planned to occur on October 27, 2025, and will be facilitated by J.P. Morgan Securities LLC. The aggregate market value of the shares to be sold is $1,815,000. The filing indicates that there have been no sales of securities by Shair in the past three months. The shares were originally acquired from the issuer on February 17, 2017, and transferred to the trust on July 13, 2021. The nature of the acquisition transaction is listed as a grant.